Haemodialysis-associated amyloidosis

Haemodialysis-associated amyloidosis
SpecialtyImmunology 

Haemodialysis-associated amyloidosis is a form of systemic amyloidosis associated with chronic kidney failure.[1] Amyloidosis is the accumulation of misfolded protein fibers in the body that can be associated with many chronic illnesses. Even though amyloidosis is common in chronic kidney disease (CKD) patients receiving chronic regular dialysis, it has also been reported in a patient with chronic kidney failure but who never received dialysis.[2]

  1. ^ Miyata T, Oda O, Inagi R, et al. (September 1993). "beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis". J. Clin. Invest. 92 (3): 1243–52. doi:10.1172/JCI116696. PMC 288264. PMID 8376584.
  2. ^ Morinière P, Marie A, El Esper N, Fardellone P, Deramond H, Remond A, Sebert JL, Fournier A (1991). "Destructive spondyloarthropathy with β2-microglobulin amyloid deposits in a uremic patient before chronic hemodialysis". Nephron. 59 (4): 654–657. doi:10.1159/000186661. PMID 1766508.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.